ENAVATE SCIENCES GP, LLC
Portfolio value QoQ: -1.7% 13F does not disclose cash
Top 10 holdings weight100.00%
Top 25 holdings weight100.00%
Positions above 1%7
Effective number of positions4.2
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 0.0% Est. buys $0 · sells $3,344,706
Median holding: 6.0 quarters Tracked Q1 2025–Q2 2026 · 100.0% still held
New positions0
Increased0
Decreased1
Closed0
Portfolio value
$345.4M
Positions
7
As of
June 30, 2026 Data as of Q2 2026
Performance vs S&P 500
Tracked Q1 2025–Q2 2026
+157.4%
S&P 500 total return (same window)
+37.0%
Excess return
+120.4%
Annualized: +113.2% · S&P 500: +28.7%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Sector breakdown
Full portfolio 7 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| SION | $109,008,540 | 31.56% | 2,478,030 | $9,664,317 | |||
| ZBIO | $99,468,255 | 28.80% | 3,919,159 | $22,848,697 | |||
| IMNM | $76,576,401 | 22.17% | 3,613,799 | $-2,457,383 | |||
| BBOT | $20,017,329 | 5.80% | 2,626,946 | $-3,493,838 | |||
| CMPX | $17,056,049 | 4.94% | 7,788,150 | $-24,143,265 | |||
| UPB | $17,021,145 | 4.93% | 2,459,703 | $-5,116,182 | |||
| CAMP | $6,229,614 | 1.80% | 1,425,541 | $-3,432,343 | Down ×3 | ||
| No matches | |||||||